ADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Esophageal or Esophagogastric Junction Cancers (SURPASS-2)

Clinical trial NCT04752358 · TERMINATED

Trial details

NCT number: NCT04752358
Sponsor: Adaptimmune
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer Esophagogastric Junction Cancer

Start date: 2021-09-15
Primary completion: 2023-06-09
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.